We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Combination of DBT and Standard Mammography Detects Breast Cancer More Often Than Mammography Alone

By MedImaging International staff writers
Posted on 28 Apr 2022
Print article
Image: Breast cancer can be detected more often than with standard mammographies (Photo courtesy of University of Münster)
Image: Breast cancer can be detected more often than with standard mammographies (Photo courtesy of University of Münster)

Breast cancer is the most frequent tumor disease worldwide. This is why, women aged 50 and over are offered systematic early detection examinations - so-called mammography screening. Now, a new study on enhanced screening technology involving almost 100,000 women has found that breast cancer can be detected more often by combining digital breast tomosynthesis (DBT) with synthetic 2D mammography than by standard mammographies.

Researchers at the University of Münster (North Rhine-Westphalia, Germany) have been conducting research in the field of innovative imaging technologies and their impact on the efficiency of detecting breast cancer at an early stage. In the ToSyMa study, a combination of DBT and so-called synthetic 2D mammograms was compared with the nowadays screening standard.

Initial results from study phase 1 confirm the assumption that by using the new enhanced mammography technology, breast cancer is detected significantly more often than by using standard mammography. This observation is based on the fact that breast tomosynthesis – an enhanced version of digital mammography – provides technology which, by computing pseudo-3D datasets, reduces any potential overlapping of tissue in the breast, thus promising benefits in making diagnoses. Phase 2 of the ToSyMa study will examine whether the increase in breast cancer diagnoses as a result of screening also leads to improved health in women.

Related Links:
University of Münster 

NMUS & MSK Ultrasound
InVisus Pro
Silver Member
X-Ray QA Meter
T3 AD Pro
New
Pocket Fetal Doppler
CONTEC10C/CL
New
MRI Infusion Workstation
BeneFusion MRI Station

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.